Cargando…
Novel non-cystic features of polycystic kidney disease: having new eyes or seeking new landscapes
For decades, researchers have been trying to decipher the complex pathophysiology of autosomal dominant polycystic kidney disease (ADPKD). So far these efforts have led to clinical trials with different candidate treatments, with tolvaptan being the only molecule that has gained approval for this in...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986322/ https://www.ncbi.nlm.nih.gov/pubmed/33777359 http://dx.doi.org/10.1093/ckj/sfaa138 |